Side Effects of Cancer Treatments for Cancer Therapy Evaluation Program (CTEP) Clinical Trials
Resources for Developing Informed Consent Side Effect Tables
- Side effect tables for CTEP IND agents and novel combinations are provided directly to the lead organization during protocol development.
- To create tables for commercially-available drugs or regimens that are not available here, follow the instructions for Building Tables of Possible Side Effects for Commercial Agents (Word).
- To create tables for agents that are not commercially available, follow the instructions for Building Tables of Possible Side Effects for Investigational Agents (Word).
- Refer to the CTEP Informed Consent Risk Term Library and CTCAE IC Terms (Excel) to identify the appropriate terms.
Comments and questions can be directed to NCICTEPComments@mail.nih.gov.
CTEP-Provided Tables of Side Effects
The downloadable lists of side effects on this page describe possible side effects that may be experienced by patients taking commonly used commercially-available cancer therapy drugs or multiple-drug regimens.
Please Note: These side effect tables for commercial agents are provided as a resource for research staff and consent document authors. These documents are not approved by the NCI CIRB as patient information sheets for use in conjunction with a clinical trial.
Only use these tables as Patient Educational Materials for a clinical trial if the IRB of record for the specific trial has reviewed and approved them for that purpose.
Before any materials can be used for patient education in conjunction with a clinical trial, they must be approved by the IRB of record. US sites participating in CTEP-supported clinical trial networks can find protocol-specific NCI CIRB-approved patient educational materials on the trial development resources page.
Find and Download a List of Drug Side Effects
Browse drugs alphabetically below or type CTRL+F to search the page for a specific drug name. For a regimen or combination of multiple cancer-treatment drugs, find the entry that includes ALL the drugs in the regimen.
5
- 5-Fluorouracil (Feb 2026)
- 5-Fluorouracil, Leucovorin (2025)
- 5-Fluorouracil, Mitomycin (2025)
- 5-Fluorouracil, Oxaliplatin, Docetaxel (FLOT) (2025)
- 5-Fluorouracil, Oxaliplatin, Paclitaxel (Apr 2026)
A
- Abemaciclib (2025)
- Abiraterone (2025)
- ABVD (Doxorubicin, Bleomycin, Vinblastine, Dacarbazine) (Apr 2026)
- Ado-trastuzumab emtansine (2025)
- Afatinib (2025)
- Alectinib hydrochloride (Apr 2026)
- Anastrozole (2023)
- Arsenic Trioxide (2023)
- Asparaginase Erwinia chrysanthemi (2024)
- Atezolizumab (2025)
- AVD (Doxorubicin, Vinblastine, Dacarbazine) (Apr 2026)
- AVD (Doxorubicin, Vinblastine, Dacarbazine), Nivolumab (2025)
- Avelumab (2025)
- Axitinib (2025)
- Azacitidine (2025)
- Azacitidine, Cytarabine (2025)
- Azacitidine, Cytarabine, Daunorubicin (2025)
- Azacitidine, Venetoclax (2025)
B
- BEACOPP (Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone) (2022)
- Belinostat (2025)
- Bendamustine (2025)
- Bevacizumab (2025)
- Bicalutamide (2023)
- Bleomycin (2024)
- Blinatumomab (2025)
- Bortezomib (2025)
- Bortezomib, Lenalidomide, Dexamethasone (2025)
- Brentuximab vedotin (2025)
- Brigatinib (2025)
- Busulfan (2023)
C
- Cabazitaxel (May 2026)
- Cabazitaxel, Prednisone (Jun 2026)
- Cabozantinib (2025)
- Calaspargase (see Pegaspargase)
- Capecitabine (Feb 2026)
- Capivasertib, Fulvestrant (2025)
- Carboplatin (2024)
- Carboplatin, Cyclophosphamide, Vincristine (2025)
- Carboplatin, Docetaxel, Pembrolizumab (2025)
- Carboplatin, Etoposide (2025)
- Carboplatin, Etoposide, Ifosfamide (2025)
- Carboplatin, Etoposide, Melphalan (2025)
- Carboplatin, Etoposide, Vincristine (2025)
- Carboplatin, Paclitaxel (2024)
- Carboplatin, Paclitxel, Bevacizumab (2025)
- Carboplatin, Paclitaxel, Pembrolizumab, Bevacizumab (2025)
- Carboplatin, Pemetrexed (2025)
- Carboplatin, Vincristine (2025)
- Carfilzomib (2023)
- Cemiplimab (2025)
- Ceritinib (2025)
- Cetuximab (2023)
- CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) (Jun 2026)
- Cisplatin (May 2026)
- Cisplatin, 5-Fluorouracil (2025)
- Cisplatin, Cyclophosphamide, Etoposide, Methotrexate, Vincristine (2021)
- Cisplatin, Doxorubicin, Methotrexate (2025)
- Cisplatin, Etoposide (2025)
- Cisplatin, Etoposide, Bleomycin (PEB) (2024)
- Cisplatin, Etoposide, Cyclophosphamide, Vincristine (2025)
- Cisplatin, Gemcitabine (Jun 2026)
- Cisplatin, Vinorelbine (2025)
- Cladribine (2023)
- Clofarabine (2023)
- Cobimetinib, Vemurafenib (2025)
- Crizotinib (2025)
- Cyclophosphamide (May 2026)
- Cyclophosphamide, Carboplatin, Etoposide (2025)
- Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Pegaspargase or Calaspargase, Thioguanine, Vincristine (2025)
- Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Pegaspargase or Calaspargase, Thioguanine, Vincristine, Nelarabine (2025)
- Cyclophosphamide, Cytarabine IV or SQ, Mercaptopurine (MP), Vincristine, and Pegaspargase or Calaspargase (2025)
- Cyclophosphamide, Cytarabine IV or SQ; Mercaptopurine (MP), Vincristine, and Pegaspargase or Calaspargase, Nelarabine (2025)
- Cyclophosphamide, Docetaxel (May 2026)
- Cyclophosphamide, Doxorubicin, Paclitaxel (2025)
- Cyclophosphamide, Doxorubicin, Vincristine (Jun 2026)
- Cyclophosphamide, Topotecan (2025)
- Cyclophosphamide, Topotecan, Dinutuximab, Sargramostim (Jan 2026)
- Cyclophosphamide, Vinorelbine (2025)
- Cytarabine (2022)
- Cytarabine (IT Ara-C) (2022)
D
- Dabrafenib (2025)
- Dacarbazine (2025)
- Dactinomycin (2022)
- Dactinomycin, Doxorubicin, Vincristine (2022)
- Dactinomycin, Vincristine (2022)
- Darolutamide (2025)
- Dasatinib (2025)
- Daunorubicin (2022)
- Daunorubicin, Cytarabine Liposome (CPX-351) see "Vyxeos"
- Daunorubicin, Pegaspargase or Calaspargase, Dexamethasone, Vincristine (2025)
- Daunorubicin, Pegaspargase or Calaspargase, Dexamethasone, Vincristine, Nelarabine (2025)
- Daunorubicin, Pegaspargase or Calaspargase, Prednisone, Vincristine (2025)
- Dexamethasone (2025)
- Dexrazoxane (2024)
- Dinutuximab, Sargramostim (Jan 2026)
- Docetaxel (May 2026)
- Docetaxel, Irinotecan (2022)
- Docetaxel, Prednisone (Jun 2026)
- Doxorubicin (Apr 2026)
- Doxorubicin, Cyclophosphamide, Paclitaxel, Carboplatin, Pembrolizumab (2025)
- Doxorubicin, Ifosfamide (May 2026)
- Durvalumab (2025)
- Durvalumab, Tremelimumab (2025)
E
- Eflornithine (DMFO) (2025)
- Enasidenib mesylate (2025)
- Encorafenib, Binimetinib (2025)
- Encorafenib, Cetuximab (2025)
- Enfortumab vedotin (2025)
- Ensartinib (2025)
- Epirubicin (2024)
- EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) (2022)
- Erdafitinib (2025)
- Eribulin mesylate (2025)
- Erlotinib (2025)
- Erlotinib, Gemcitabine (2022)
- Etoposide (Apr 2026)
- Etoposide, Ifosfamide (2025)
- Everolimus (2024)
- Exemestane (2023)
F
- Filgrastim (2023)
- Fludarabine (2022)
- Fludarabine, Cytarabine (2022)
- Flutamide (2025)
- FOLFIRI (Leucovorin, 5-Fluorouracil, Irinotecan) (2025)
- FOLFIRINOX (Leucovorin, 5-Fluorouracil, Irinotecan, Oxaliplatin) (2025)
- FOLFOX (Leucovorin, 5-Fluorouracil, Oxaliplatin) (2025)
- Fruquintinib (2025)
- Fulvestrant (2023)
G
- Gemcitabine (Apr 2026)
- Gemcitabine, Paclitaxel Protein-Bound Particles (2023)
- Gemtuzumab ozogamicin (2025)
- Gilteritinib (2025)
- Goserelin (2025)
H
I
- Ibritumomab (2023)
- Ibrutinib (2025)
- Idarubicin (2023)
- Ifosfamide (May 2026)
- Imatinib (2025)
- Inotuzumab ozogamicin (2025)
- Intrathecal Therapy (Methotrexate, Cytarabine, Triple Intrathecal Therapy) (2025)
- Inqovi (Decitabine and Cedazuridine) (2025)
- Ipilimumab (2025)
- Irinotecan (2024)
- Irinotecan, Temozolomide (2025)
- Irinotecan, Temozolomide, Dinutuximab, Sargramostim (2025)
- Isotretinoin (2023)
- Isotretinoin, Dinutuximab, Sargramostim (Jan 2026)
- Ivosidenib (Apr 2026)
- Ixazomib, Lenalidomide, Dexamethasone (Apr 2026)
L
- Larotrectinib (2025)
- Lenalidomide (2025)
- Letrozole (2023)
- Leucovorin (2023)
- Leuprolide (2022)
- Liposomal doxorubicin (Apr 2026)
- Lomustine (2024)
- Lonsurf (Trifluridine and Tipiracil) (2025)
- Lorlatinib (2025)
- Lutetium Lu 177 dotatate (2025)
M
- Melphalan (2025)
- Mercaptopurine (2023)
- Mercaptopurine PO, Methotrexate PO, Dexamethasone, Vincristine (Apr 2026)
- Mercaptopurine PO, Methotrexate PO, Dexamethasone, Vincristine, Nelarabine (Apr 2026)
- Mercaptopurine PO, Methotrexate PO, Prednisone, Vincristine (Apr 2026)
- Mesna (2022)
- Methotrexate (ITMTX) (Apr 2026)
- Methotrexate (not ITMTX) (Apr 2026)
- Methotrexate, Vinblastine, Doxorubicin, Cisplatin (Apr 2026)
- Methylprednisolone (2025)
- Mitotane (2023)
- Mitoxantrone (2023)
- Mosunetuzumab (2025)
N
- Necitumumab, Gemcitabine, Cisplatin (2025)
- Nelarabine (2025)
- Neratinib (2025)
- Nilotinib (2024)
- Nilutamide (Apr 2026)
- Niraparib (2025)
- Nivolumab (2025)
O
- Obinutuzumab, Bendamustine (Feb 2026)
- Obinutuzumab, Chlorambucil (2025)
- Octreotide (2023)
- Octreotide, Lanreotide (2025)
- Olaparib (2025)
- Olaparib, Bevacizumab (2025)
- Opdualag (Nivolumab and Relatlimab) (2025)
- Osimertinib (2025)
- Oxaliplatin (2024)
P
- Paclitaxel (2024)
- Paclitaxel protein-bound particles (same as Nab-paclitaxel) (2023)
- Palbociclib, Fulvestrant (2025)
- Palbociclib, Fulvestrant, Inavolisib (2025)
- Palbociclib, Letrozole (2025)
- Panitumumab (2024)
- Pazopanib (2025)
- Pazopanib, Trabectedin, Doxorubicin (Apr 2026)
- Pegaspargase or Calaspargase (2024)
- Pegaspargase or Calaspargase, Vincristine (2025)
- Pegaspargase or Calaspargase, Vincristine, Methotrexate IV (2025)
- Pegfilgrastim (2023)
- Pembrolizumab (2025)
- Pembrolizumab, Bevacizumab (2025)
- Pertuzumab, Trastuzumab, Docetaxel (2025)
- Pemetrexed (2024)
- Pentostatin (2024)
- Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) (2025)
- Pomalidomide (2025)
- Ponatinib (2024)
- Prednisone (Jun 2026)
- Procarbazine (Jun 2026)
R
- Radium-223 dichloride (2025)
- Ramucirumab (2025)
- Regorafenib (2025)
- Rituximab (2023)
- Rucaparib (2025)
S
- Sacituzumab govitecan (2025)
- Sargramostim (2025)
- Selinexor (2025)
- Selpercatinib (2025)
- Selumetinib (Apr 2026)
- Sotorasib (2025)
- Sunitinib malate (2025)
- Sunitinib malate, Everolimus (2025)
T
- Talazoparib (2025)
- Tamoxifen (2023)
- Tazemetostat (2025)
- Teclistamab (2025)
- Temozolomide (2023)
- Thioguanine (2025)
- Thiotepa (2023)
- Thiotepa, Cyclophosphamide (2025)
- Tocilizumab (2025)
- Topotecan (2024)
- Tovorafenib (2025)
- Trabectedin (2025)
- Trametinib (2025)
- Trastuzumab (2024)
- Trastuzumab deruxtecan (2025)
- Tremelimumab (2025)
- Tretinoin (2023)
- Triple Intrathecals (see Intrathecal Therapy)
- Triptorelin (2023)
- Tucatinib, Trastuzumab (2025)
- T-VEC (Talimogene laherparepvec) (2025)
V
- VAC (Vincristine, Dactinomycin, Cyclophosphamide) (2022)
- Vandetanib (2024)
- Vemurafenib (2025)
- Venetoclax (2025)
- Vinblastine (Apr 2026)
- Vincristine (2024)
- Vincristine, Cyclophosphamide (Jun 2026)
- Vincristine, Irinotecan (2022)
- Vincristine, Pegaspargase or Calaspargase, Prednisone (2025)
- Vinorelbine (2024)
- Vismodegib (2025)
- Vorinostat (2025)
- Vyxeos (Daunorubicin and Cytarabine Liposome) (2023)
Z
- Ziv-aflibercept, FOLFIRI (2025)